Azelaic acid foam 15% + Vehicle foam
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Papulopustular Rosacea
Conditions
Papulopustular Rosacea
Trial Timeline
Dec 1, 2009 → Aug 1, 2010
NCT ID
NCT01025635About Azelaic acid foam 15% + Vehicle foam
Azelaic acid foam 15% + Vehicle foam is a phase 2 stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT01025635. Target conditions include Papulopustular Rosacea.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01025635 | Phase 2 | Completed |
Competing Products
18 competing products in Papulopustular Rosacea